)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Lantern Pharma (LTRN) investor relations material
Lantern Pharma Investor Update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investor Update summary26 Aug, 2025
Business and operational overview
Focuses on AI-driven development of precision oncology medicines, with three clinical-stage small molecules and a robust preclinical pipeline, including antibody drug conjugates.
Maintains a disciplined fiscal profile with a quarterly burn rate of $4.5M, cash runway into 2026, no debt, and approximately 12M fully diluted shares.
Holds 11 FDA designations (5 orphan, 4 rare pediatric, 2 fast track) and about 140 issued and pending patents covering composition, methods, and AI platform innovations.
Business model centers on early innovation, rapid execution, and out-licensing assets to larger pharma partners.
Clinical pipeline and trial updates
LP-300 in Phase II targets never-smoker non-small cell lung cancer, a $4–5B global market, with strong early data and expansion into Japan and Taiwan.
LP-184 completed Phase I enrollment (65 patients) across multiple solid tumors; moving to Phase Ib/II in TNBC, STK11/KEAP1-mutated lung cancer, and bladder cancer.
LP-284, a sister drug to LP-184, is in trials for B-cell lymphomas, showing a complete metabolic response in a patient who failed multiple prior therapies.
Combination therapy strategies are a major focus, with promising preclinical synergy between LP-184 and PARP inhibitors in TNBC and checkpoint inhibitors in lung cancer.
AI platform and technology strategy
AI platform (RADAR) is central to drug discovery, enabling rapid, iterative modeling and prediction for molecule selection, trial design, and combination strategies.
Public release of PredictBBB.ai module allows users to predict blood-brain barrier penetrability with high accuracy, supporting both internal and external collaborations.
Future modules will expand predictive capabilities to additional molecular properties, aiming to disrupt traditional drug development timelines and costs.
AI platform is being commercialized via a freemium model, with free trials and paid tokens or collaborations for extended use.
How will public AI modules drive collaborations?
What is LP-300's market differentiation?
How does AI inform combination therapy strategy?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Lantern Pharma earnings date
Q3 202514 Nov, 2025
Next Lantern Pharma earnings date
Q3 202514 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Lantern Pharma Inc. is a clinical-stage biotechnology company focused on leveraging artificial intelligence and genomic data to develop precision oncology therapeutics. The company’s pipeline targets a range of cancers with the aim of enhancing treatment outcomes and reducing development risks. Lantern Pharma Inc. is headquartered in Dallas, Texas, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage